Researchers analyzed results of an acute myocardial infarction trial that included patients from the United States, Canada, Australia, New Zealand and 13 European countries from 2004-2006. They found that the 30-day readmission rate for ST-segment elevation myocardial infarction patients was 14.5 percent in the United States compared to 9.9 percent in other countries.
Median length of stay was shortest in the United States at 3 days compared to 8 days in Germany. After adjusting for country-level median length of stay, U.S. location was no longer an independent predictor of 30-day readmission.
Related Articles on Hospital Cardiology:
Baptist Health Partners With Arkansas Cardiology in Heart Institute
CaroMont Health Acquires Mid Carolina Cardiology From Novant
Study: Proficiency May be Attained After 30 Transfemoral Aortic Valve Implantations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.